Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Classical hematology 1Breast 1

Conditions

Breast Neoplasms 39Colonic Neoplasms 14Colorectal Neoplasms 13Neoplasms 12Rectal Neoplasms 11Prostatic Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Uterine Cervical Neoplasms 8Obesity 8Motor Activity 8Lung Neoplasms 8Endometrial Neoplasms 8Tobacco Use Disorder 6Small Cell Lung Carcinoma 6Overweight 6Depression 6Pancreatic Neoplasms 5Ovarian Neoplasms 5Leukemia, Myeloid, Acute 5Fatigue 5Breast Carcinoma In Situ 5Anxiety Disorders 5Urinary Bladder Neoplasms 4Sexuality 4Sexual Dysfunction, Physiological 4Leukemia 4Head and Neck Neoplasms 4Carcinoma, Renal Cell 4Carcinoma, Intraductal, Noninfiltrating 4Body Weight Changes 4

Interventions

olaparib 9Carboplatin 3talazoparib 1pembrolizumab 1liposomal doxorubicin 1iniparib 1Trabectedin 1Surveys and Questionnaires 1Secretin 1Paclitaxel 1Genotype 1Genetic Counseling 1Demography 1Data Collection 1Counseling 1Cognitive Behavioral Therapy 1Biopsy, Fine-Needle 1ABT-767 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fanconi Anemia, Complementation Group D1 × Counseling × Clear all
NCT00001806 2019-12-12

Methods in Education for Breast Cancer Genetics

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
170 enrolled
BreastClassical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡